ARCHIVES

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

In Brief: ACS Massachusetts Div. Offers $1,500 Grants To Improve community Hospital Cancer Care

March 2, 1979